Ibandronate sodium monohydrate is a synthetic nitrogen-containing bisphosphonate compound used as an active pharmaceutical ingredient. It acts by inhibiting farnesyl pyrophosphate synthase, which reduces osteoclast activity and bone resorption.
Escopo do conteúdo: As informações desta página dizem respeito à identificação química e aos contextos de fornecimento industrial, pesquisa e produção. Não constituem alegação terapêutica, aconselhamento médico ou instruções de uso de medicamentos.
Adquirindo ou fornecendo este composto?
Publique seu inventário ou uma solicitação de compra
CAS 138926-19-9
Ibandronate sodium anhydrous
active pharmaceutical ingredient
Ziprasidone hydrochloride monohydrate
active pharmaceutical ingredient
Diethyl(2-(2-phenylbutyroyloxy)ethyl)ammonium dihydrogen citrate
active pharmaceutical ingredient
7-HYDROXYQUETIAPINE
pharmaceutical impurity reference standard
Isobutyl Sildenafil
active pharmaceutical ingredient impurity
Ibandronic Acid
bisphosphonate active pharmaceutical ingredient
Ibandronic Acid-d3 Sodium Salt
active pharmaceutical ingredient
sodium;hydroxy-[1-hydroxy-3-[methyl(pentyl)amino]-1-phosphonopropyl]phosphinate;hydrate
VBDRTGFACFYFCT-UHFFFAOYSA-M
CCCCCN(C)CCC(O)(P(=O)(O)O)P(=O)(O)[O-].O.[Na+]